引入生物标志物。 - Suppr | 超能文献

相似文献

1

Bring on the biomarkers.引入生物标志物。

Nature. 2011 Jan 13;469(7329):156-7. doi: 10.1038/469156a.

2

Tabula Rasa HealthCare company profile: involvement in pharmacogenomic and personalized medicine research.白板医疗保健公司简介：参与药物基因组学和个性化医学研究。

Pharmacogenomics. 2021 Aug;22(12):731-735. doi: 10.2217/pgs-2021-0085. Epub 2021 Jul 21.

3

Role of pharmacogenetics in public health and clinical health care: a SWOT analysis.药物遗传学在公共卫生与临床医疗保健中的作用：一项SWOT分析。

Eur J Hum Genet. 2016 Dec;24(12):1651-1657. doi: 10.1038/ejhg.2016.114. Epub 2016 Aug 31.

4

Personalized medicine: Bring clinical standards to human-genetics research.个性化医疗：将临床标准引入人类遗传学研究。

Nature. 2012 Feb 15;482(7385):300-1. doi: 10.1038/482300a.

5

Genetics research: Clinical standards not practical in the lab.遗传学研究：临床标准在实验室中不实用。

Nature. 2012 Mar 7;483(7388):158. doi: 10.1038/483158c.

6

Implementing personalized medicine: development of a cost-effective customized pharmacogenetics genotyping array.实施个性化医学：开发一种具有成本效益的定制型药物基因组学分型基因芯片。

Clin Pharmacol Ther. 2012 Oct;92(4):437-9. doi: 10.1038/clpt.2012.125. Epub 2012 Aug 22.

7

Health: Make precision medicine work for cancer care.健康：让精准医疗在癌症治疗中发挥作用。

Nature. 2015 Apr 16;520(7547):290-1. doi: 10.1038/520290a.

8

Biobanks and personalized medicine.生物样本库与个性化医疗。

Clin Genet. 2014 Jul;86(1):50-5. doi: 10.1111/cge.12370. Epub 2014 Mar 27.

9

Current needs for human and medical genomics research infrastructure in low and middle income countries.低收入和中等收入国家人类与医学基因组学研究基础设施的当前需求

J Med Genet. 2016 Jul;53(7):438-40. doi: 10.1136/jmedgenet-2015-103631. Epub 2016 Jan 6.

10

From Illumination to Innovation: Visualizing the Future-The 2015 Presidential Address.从照明到创新：展望未来——2015年主席致辞

J Clin Oncol. 2016 Aug 10;34(23):2679-83. doi: 10.1200/JCO.2016.68.6923. Epub 2016 Jun 27.

引用本文的文献

1

Serum Levels of HMGB1, hS100A8/A9, and sRAGE in Patients with Knee and Hip Osteoarthritis: Inflammatory Biomarkers of Disease Activity.膝骨关节炎和髋骨关节炎患者血清中HMGB1、hS100A8/A9和sRAGE水平：疾病活动的炎症生物标志物

J Clin Med. 2025 Aug 22;14(17):5931. doi: 10.3390/jcm14175931.

2

Novel Method for Routine Ultrasound-Guided Serum Collection for Biomarker Analysis Around the Knee Joint.用于膝关节周围生物标志物分析的常规超声引导下血清采集的新方法。

F1000Res. 2025 Jan 13;14:68. doi: 10.12688/f1000research.159920.1. eCollection 2025.

3

Serum Proteomic Signatures of Pregnancy-associated Breast Cancer.

本文引用的文献

1

Which way for genetic-test regulation? Assign regulation appropriate to the level of risk.基因检测监管何去何从？根据风险水平进行适当监管。

Nature. 2010 Aug 12;466(7308):817-8. doi: 10.1038/466817a.

2

Sources of bias in specimens for research about molecular markers for cancer.用于癌症分子标志物研究标本的偏倚来源。

J Clin Oncol. 2010 Feb 1;28(4):698-704. doi: 10.1200/JCO.2009.25.6065. Epub 2009 Dec 28.

3

Personalized medicine: factors influencing reimbursement.个性化医学：影响报销的因素。